Singh, R., Gautam, A., Chandel, S., Sharma, V., Ghosh, A., Dey, D., . . . Ghosh, D. (2021). Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post‐translational modification: A multiple target approach. In Silico Pharmacol.

Singh, Rajveer, Anupam Gautam, Shivani Chandel, Vipul Sharma, Arijit Ghosh, Dhritiman Dey, Syamal Roy, V. Ravichandiran, e Dipanjan Ghosh. "Computational Screening of FDA Approved Drugs of Fungal Origin That May Interfere With SARS-CoV-2 Spike Protein Activation, Viral RNA Replication, and Post‐translational Modification: A Multiple Target Approach." In Silico Pharmacol 2021.

Singh, Rajveer, et al. "Computational Screening of FDA Approved Drugs of Fungal Origin That May Interfere With SARS-CoV-2 Spike Protein Activation, Viral RNA Replication, and Post‐translational Modification: A Multiple Target Approach." In Silico Pharmacol 2021.